White Paper: CHO Quasispecies – Implications for Manufacturing Processes Now Available The White Paper CHO Quasispecies – Implications for Manufacturing Processes is now freely available for viewing on our website. First published in Processes Journal in 2013, it has...
Talks: Single-Use Bioreactors and Disposable Process Materials: How-To and Issues @ Disposable Solutions Berlin, Feb 19 Disposable materials in bioprocessing and single-use bioreactors have become widely used standards in R&D at small scale as well as cGMP based...
White Paper: Recombinant Proteins for Industrial versus Pharmaceutical Purposes: A Review of Process and Pricing Prof. Florian Wurm (ExcellGene CSO) and John Puetz from the Department of Pediatrics, Division of Hematology/Oncology at Saint Louis University School of...
Talk: Strategies to Improve Titers and Product Quality @ BioProduction 2019 ExcellGene attended BioProduction 2019 in Frankfurt, November 5-7th 2019. Prof. Florian Wurm spoke under the cell line development track to cover strategies for improving yield and quality of...
White Paper: Cloning of CHO Cells, Productivity and Genetic Stability, Best Paper Award, Keynote Lecture on CHONew White Paper and Best Paper AwardWe are pleased to announce that the paper Cloning of CHO Cells, Productivity and Genetic Stability – A Discussion was...
A New Ebola Vaccine: ExcellGene in a Euro-Swiss Initiative The repeated Ebola virus outbreaks in West Africa have reached historic proportions and underscore the vulnerability of populations to pathogens. Outbreaks of infection by the Zaire Ebola virus have been...
